Works by Tokunaga, Shinya


Results: 27
    1
    2
    3
    4
    5
    6
    7
    8

    Prospective Study of Urinary and Serum Cross-Linked N-Telopeptide of Type I Collagen (NTx) for Diagnosis of Bone Metastasis in Patients With Lung Cancer.

    Published in:
    Clinical Lung Cancer, 2013, v. 14, n. 4, p. 364, doi. 10.1016/j.cllc.2012.11.006
    By:
    • Tamiya, Motohiro;
    • Tokunaga, Shinya;
    • Okada, Hideaki;
    • Suzuki, Hidekazu;
    • Kobayashi, Masashi;
    • Sasada, Shinji;
    • Okamoto, Norio;
    • Morishita, Naoko;
    • Matsuura, Yuka;
    • Miyamoto, Natsuko;
    • Hattori, Michiyo;
    • Taira, Koichi;
    • Daga, Haruko;
    • Takeda, Koji;
    • Hirashima, Tomonori
    Publication type:
    Article
    9

    Phase I study of nanoparticle albumin-bound paclitaxel, carboplatin and trastuzumab in women with human epidermal growth factor receptor 2-overexpressing breast cancer.

    Published in:
    Molecular & Clinical Oncology, 2017, v. 6, n. 4, p. 534, doi. 10.3892/mco.2017.1176
    By:
    • KENJI TEZUKA;
    • TSUTOMU TAKASHIMA;
    • SHINICHIRO KASHIWAGI;
    • HIDEMI KAWAJIRI;
    • SHINYA TOKUNAGA;
    • SEIKA TEI;
    • SHIGEHIKO NISHIMURA;
    • SHIGEHITO YAMAGATA;
    • SATORU NODA;
    • TAKEO NISHIMORI;
    • YOKO MIZUYAMA;
    • TAKESHI SUNAMI;
    • KATSUMI IKEDA;
    • YOSHINARI OGAWA;
    • NAOYOSHI ONODA;
    • TETSURO ISHIKAWA;
    • SHINZOH KUDOH;
    • MINORU TAKADA;
    • KOSEI HIRAKAWA
    Publication type:
    Article
    10

    Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G).

    Published in:
    Gastric Cancer, 2018, v. 21, n. 1, p. 84, doi. 10.1007/s10120-017-0725-6
    By:
    • Miura, Yuji;
    • Sukawa, Yasutaka;
    • Hironaka, Shuichi;
    • Mori, Misuzu;
    • Nishikawa, Kazuhiro;
    • Tokunaga, Shinya;
    • Okuda, Hiroyuki;
    • Sakamoto, Takeshi;
    • Taku, Keisei;
    • Nishikawa, Kazuo;
    • Moriwaki, Toshikazu;
    • Negoro, Yuji;
    • Kimura, Yutaka;
    • Uchino, Keita;
    • Shinozaki, Katsunori;
    • Shinozaki, Hiroharu;
    • Musha, Nobuyuki;
    • Yoshiyama, Hirotsugu;
    • Tsuda, Takashi;
    • Miyata, Yoshinori
    Publication type:
    Article
    11

    A study of second-line irinotecan plus cisplatin vs. irinotecan alone in platinum-naïve patients with early relapse of gastric cancer refractory to adjuvant S-1 monotherapy: exploratory subgroup analysis of the randomized phase III TRICS trial.

    Published in:
    2019
    By:
    • Nishikawa, Kazuhiro;
    • Murotani, Kenta;
    • Fujitani, Kazumasa;
    • Inagaki, Hitoshi;
    • Akamaru, Yusuke;
    • Tokunaga, Shinya;
    • Takagi, Masakazu;
    • Tamura, Shigeyuki;
    • Sugimoto, Naotoshi;
    • Shigematsu, Tadashi;
    • Yoshikawa, Takaki;
    • Ishiguro, Tohru;
    • Nakamura, Masato;
    • Hasegawa, Hiroko;
    • Morita, Satoshi;
    • Miyashita, Yumi;
    • Tsuburaya, Akira;
    • Sakamoto, Junichi;
    • Tsujinaka, Toshimasa
    Publication type:
    journal article
    12

    A double‐blind, randomized, multicenter phase 3 study of palonosetron vs granisetron combined with dexamethasone and fosaprepitant to prevent chemotherapy‐induced nausea and vomiting in patients with breast cancer receiving anthracycline and cyclophosphamide

    Published in:
    Cancer Medicine, 2020, v. 9, n. 10, p. 3319, doi. 10.1002/cam4.2979
    By:
    • Matsumoto, Koji;
    • Takahashi, Masato;
    • Sato, Kazuhiko;
    • Osaki, Akihiko;
    • Takano, Toshimi;
    • Naito, Yoichi;
    • Matsuura, Kazuo;
    • Aogi, Kenjiro;
    • Fujiwara, Kimiko;
    • Tamura, Kenji;
    • Baba, Motoi;
    • Tokunaga, Shinya;
    • Hirano, Gen;
    • Imoto, Shigeru;
    • Miyazaki, Chieko;
    • Yanagihara, Kazuhiro;
    • Imamura, Chiyo K.;
    • Chiba, Yasutaka;
    • Saeki, Toshiaki
    Publication type:
    Article
    13
    14
    15
    16

    Gemcitabine and Vinorelbine Combination Chemotherapy in Taxane-Pretreated Patients with Metastatic Breast Cancer: A Phase II Study of the Kinki Multidisciplinary Breast Oncology Group (KMBOG) 1015.

    Published in:
    Chemotherapy (0009-3157), 2017, v. 62, n. 5, p. 307, doi. 10.1159/000475879
    By:
    • Yamamura, Jun;
    • Masuda, Norikazu;
    • Yamamoto, Daigo;
    • Tsuyuki, Shigeru;
    • Yamaguchi, Masahide;
    • Tanaka, Satoru;
    • Tsurutani, Junji;
    • Tokunaga, Shinya;
    • Yoshidome, Katsuhide;
    • Mizutani, Makiko;
    • aono, Toyokazu;
    • Ooe, asako;
    • Tanino, Hirokazu;
    • Matsunami, Nobuki;
    • Yasojima, Hiroyuki;
    • Nakayama, Takahiro;
    • Nishida, Yukihiro
    Publication type:
    Article
    17

    Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild‐type metastatic colorectal cancer: A phase II trial (HYBRID).

    Published in:
    Cancer Medicine, 2024, v. 13, n. 7, p. 1, doi. 10.1002/cam4.7107
    By:
    • Arai, Hiroyuki;
    • Tsuda, Takashi;
    • Sunakawa, Yu;
    • Shimokawa, Mototsugu;
    • Akiyoshi, Kohei;
    • Tokunaga, Shinya;
    • Shoji, Hirokazu;
    • Kunieda, Kenji;
    • Kotaka, Masahito;
    • Matsumoto, Toshihiko;
    • Nagata, Yusuke;
    • Mizukami, Takuro;
    • Mizuki, Fumitaka;
    • Danenberg, Kathleen D.;
    • Boku, Narikazu;
    • Nakajima, Takako Eguchi
    Publication type:
    Article
    18
    19
    20

    A phase 2 study of adjuvant chemotherapy with 5‐fluorouracil/leucovorin and oxaliplatin after lung metastasectomy for colorectal cancer (WJOG5810G).

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 7, p. 1, doi. 10.1002/cncr.35807
    By:
    • Machida, Nozomu;
    • Okumura, Takehiro;
    • Boku, Narikazu;
    • Kishimoto, Junji;
    • Nishina, Tomohiro;
    • Suyama, Koichi;
    • Ohde, Yasuhisa;
    • Shinozaki, Katsunori;
    • Baba, Hideo;
    • Tokunaga, Shinya;
    • Kawakami, Hisato;
    • Tsuda, Takashi;
    • Kotaka, Masahito;
    • Okuda, Hiroyuki;
    • Yasui, Hisateru;
    • Yamazaki, Kentaro;
    • Hironaka, Shuichi;
    • Muro, Kei;
    • Hyodo, Ichinosuke
    Publication type:
    Article
    21
    22
    23
    24
    25

    A phase 3 non-inferiority study of 5-FU/ l-leucovorin/irinotecan (FOLFIRI) versus irinotecan/S-1 (IRIS) as second-line chemotherapy for metastatic colorectal cancer: updated results of the FIRIS study.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 1, p. 153, doi. 10.1007/s00432-014-1783-3
    By:
    • Yasui, Hirofumi;
    • Muro, Kei;
    • Shimada, Yasuhiro;
    • Tsuji, Akihito;
    • Sameshima, Shinichi;
    • Baba, Hideo;
    • Satoh, Taroh;
    • Denda, Tadamichi;
    • Ina, Kenji;
    • Nishina, Tomohiro;
    • Yamaguchi, Kensei;
    • Esaki, Taito;
    • Tokunaga, Shinya;
    • Kuwano, Hiroyuki;
    • Boku, Narikazu;
    • Komatsu, Yoshito;
    • Watanabe, Masahiko;
    • Hyodo, Ichinosuke;
    • Morita, Satoshi;
    • Sugihara, Kenichi
    Publication type:
    Article
    26
    27